183,138 Shares in Corteva, Inc. $CTVA Acquired by Nykredit A S

Nykredit A S acquired a new stake in Corteva, Inc. (NYSE:CTVA) during the 2nd quarter, HoldingsChannel reports. The firm acquired 183,138 shares of the company’s stock, valued at approximately $15,510,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. EFG International AG bought a new stake in shares of Corteva in the second quarter valued at $25,000. Compass Financial Management LLC bought a new position in shares of Corteva during the 2nd quarter worth $25,000. JPL Wealth Management LLC purchased a new stake in Corteva in the 3rd quarter worth about $25,000. Garton & Associates Financial Advisors LLC purchased a new stake in Corteva in the 4th quarter worth about $27,000. Finally, Bank of Jackson Hole Trust bought a new stake in Corteva in the 4th quarter valued at about $28,000. 81.54% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have weighed in on CTVA. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $101.00 target price on shares of Corteva in a research report on Monday, August 3rd. UBS Group dropped their price target on shares of Corteva from $89.00 to $85.00 and set a “neutral” rating on the stock in a research note on Tuesday, August 18th. Zacks Research downgraded shares of Corteva from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 11th. Mizuho lifted their price objective on shares of Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a research note on Tuesday, July 14th. Finally, Weiss Ratings cut shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, August 3rd. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat.com, Corteva has an average rating of “Moderate Buy” and an average target price of $91.50.

Corteva Stock Down 0.9%

CTVA stock opened at $87.78 on Friday. The stock has a 50-day simple moving average of $83.42 and a two-hundred day simple moving average of $81.00. Corteva, Inc. has a twelve month low of $60.53 and a twelve month high of $90.97. The firm has a market capitalization of $58.57 billion, a PE ratio of 58.13, a PEG ratio of 2.72 and a beta of 0.57. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The firm had revenue of $6.38 billion for the quarter, compared to the consensus estimate of $6.60 billion. During the same period in the prior year, the firm posted $2.20 earnings per share. The company’s revenue for the quarter was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, equities analysts predict that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be paid a $0.18 dividend. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 annualized dividend and a yield of 0.8%. Corteva’s dividend payout ratio is currently 47.68%.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.